title: Brain metastases in patients with renal cell cancer receiving new targeted treatment.
authors.affiliation: Department of Medical Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
authors.forename: Helgi H
authors.initials: HH
authors.lastname: Helgason
authors.forename: Henk A
authors.initials: HA
authors.lastname: Mallo
authors.forename: Helga
authors.initials: H
authors.lastname: Droogendijk
authors.forename: John G
authors.initials: JG
authors.lastname: Haanen
authors.forename: Astrid A M
authors.initials: AA
authors.lastname: van der Veldt
authors.forename: Alfonsus J
authors.initials: AJ
authors.lastname: van den Eertwegh
authors.forename: Epie
authors.initials: E
authors.lastname: Boven
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib